Literature DB >> 22556163

Adrenodoxin--a versatile ferredoxin.

Kerstin Maria Ewen1, Michael Ringle, Rita Bernhardt.   

Abstract

Mammalian adrenodoxin (Adx) has been known for many years as an essential electron mediator in mitochondrial cytochrome P450 systems. Because of its ability to support several cytochrome P450 enzymes, it is involved not only in adrenal steroid hormone biosynthesis but also in vitamin D and bile acid metabolism. Recently, Adx is increasingly gaining attention because of its potential for pharmaceutical industry and biotechnology. With human cytochromes P450 becoming important drug targets, suitable Adx-based screening systems have to be developed to test putative new drugs. Moreover, in artificial systems, Adx has been shown to functionally interact with diverse bacterial cytochromes P450 catalyzing a variety of chemically interesting reactions. Putative biotechnological applications of such Adx-containing reconstituted systems are discussed.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22556163     DOI: 10.1002/iub.1029

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  16 in total

Review 1.  Evolution of Chlamydomonas reinhardtii ferredoxins and their interactions with [FeFe]-hydrogenases.

Authors:  Anne Sawyer; Martin Winkler
Journal:  Photosynth Res       Date:  2017-06-15       Impact factor: 3.573

2.  Solution structure for an Encephalitozoon cuniculi adrenodoxin-like protein in the oxidized state.

Authors:  Shareef Shaheen; Kayleigh F Barrett; Sandhya Subramanian; Samuel L M Arnold; Joseph A Laureanti; Peter J Myler; Wesley C Van Voorhis; Garry W Buchko
Journal:  Protein Sci       Date:  2020-01-20       Impact factor: 6.725

3.  Partial fusion of a cytochrome P450 system by carboxy-terminal attachment of putidaredoxin reductase to P450cam (CYP101A1).

Authors:  Eachan O Johnson; Luet-Lok Wong
Journal:  Catal Sci Technol       Date:  2016-09-01       Impact factor: 6.119

4.  A CYP21A2 based whole-cell system in Escherichia coli for the biotechnological production of premedrol.

Authors:  Simone Brixius-Anderko; Lina Schiffer; Frank Hannemann; Bernd Janocha; Rita Bernhardt
Journal:  Microb Cell Fact       Date:  2015-09-15       Impact factor: 5.328

5.  Steroid conversion with CYP106A2 - production of pharmaceutically interesting DHEA metabolites.

Authors:  Daniela Schmitz; Josef Zapp; Rita Bernhardt
Journal:  Microb Cell Fact       Date:  2014-06-05       Impact factor: 5.328

6.  Process development for the production of 15β-hydroxycyproterone acetate using Bacillus megaterium expressing CYP106A2 as whole-cell biocatalyst.

Authors:  Flora M Kiss; Marie T Lundemo; Josef Zapp; John M Woodley; Rita Bernhardt
Journal:  Microb Cell Fact       Date:  2015-03-05       Impact factor: 5.328

7.  Human Mitochondrial Ferredoxin 1 (FDX1) and Ferredoxin 2 (FDX2) Both Bind Cysteine Desulfurase and Donate Electrons for Iron-Sulfur Cluster Biosynthesis.

Authors:  Kai Cai; Marco Tonelli; Ronnie O Frederick; John L Markley
Journal:  Biochemistry       Date:  2017-01-11       Impact factor: 3.162

8.  Carrier Protein-Free Enzymatic Biaryl Coupling in Arylomycin A2 Assembly and Structure of the Cytochrome P450 AryC.

Authors:  Hülya Aldemir; Shuangjie Shu; Francoise Schaefers; Hanna Hong; René Richarz; Sabrina Harteis; Manuel Einsiedler; Tobias M Milzarek; Sabine Schneider; Tobias A M Gulder
Journal:  Chemistry       Date:  2021-11-26       Impact factor: 5.020

9.  Cluster and fold stability of E. coli ISC-type ferredoxin.

Authors:  Robert Yan; Salvatore Adinolfi; Clara Iannuzzi; Geoff Kelly; Alain Oregioni; Stephen Martin; Annalisa Pastore
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

10.  Ferredoxin 1b (Fdx1b) Is the Essential Mitochondrial Redox Partner for Cortisol Biosynthesis in Zebrafish.

Authors:  Aliesha Griffin; Silvia Parajes; Meltem Weger; Andreas Zaucker; Angela E Taylor; Donna M O'Neil; Ferenc Müller; Nils Krone
Journal:  Endocrinology       Date:  2015-12-09       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.